Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Global Cardiology Science & Practice
|
November 12, 2020
Pulmonary hypertension: Proteins in the blood
Martin Wilkins
Scientific Reports
|
November 30, 2024
Deep phenotyping the right ventricle to establish translational MRI biomarkers for characterization of adaptive and maladaptive states in pulmonary hypertension
Nicoleta Baxan, Lin Zhao, Ali Ashek, et al.
Communications Biology
|
August 25, 2021
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov, et al.
JACC. Basic to Translational Science
|
May 29, 2026
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated Hepatopathy
Madelyn J Blake, Jason Hong, Adam Brownstein, et al.
Pulmonary Circulation
|
July 10, 2025
Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta-Registry
Arun Jose, Athiththan Yogeswaran, Meike Fuenderich, et al.
Pulmonary Circulation
|
March 19, 2024
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies
Frances Varian, Jennifer Dick, Christian Battersby, et al.
The European Respiratory Journal
|
July 26, 2024
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies
S Ashwin Reddy, Joseph Newman, Olivia C Leavy, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Global Cardiology Science & Practice
|
November 12, 2020
Pulmonary hypertension: Proteins in the blood
Martin Wilkins
Scientific Reports
|
November 30, 2024
Deep phenotyping the right ventricle to establish translational MRI biomarkers for characterization of adaptive and maladaptive states in pulmonary hypertension
Nicoleta Baxan, Lin Zhao, Ali Ashek, et al.
Communications Biology
|
August 25, 2021
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov, et al.
JACC. Basic to Translational Science
|
May 29, 2026
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated Hepatopathy
Madelyn J Blake, Jason Hong, Adam Brownstein, et al.
Pulmonary Circulation
|
July 10, 2025
Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta-Registry
Arun Jose, Athiththan Yogeswaran, Meike Fuenderich, et al.
Pulmonary Circulation
|
March 19, 2024
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies
Frances Varian, Jennifer Dick, Christian Battersby, et al.
The European Respiratory Journal
|
July 26, 2024
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies
S Ashwin Reddy, Joseph Newman, Olivia C Leavy, et al.
Page
of 1